MULTIPLYING THE POSSIBILITIES Trademark
Trademark Overview
On Thursday, March 28, 2024, a trademark application was filed for MULTIPLYING THE POSSIBILITIES with the United States Patent and Trademark Office. The USPTO has given the MULTIPLYING THE POSSIBILITIES trademark a serial number of 98473700. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 28, 2024. This trademark is owned by CAPSTAN THERAPEUTICS, INC.. The MULTIPLYING THE POSSIBILITIES trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; systems to express therapeutic proteins in vivo; biopharmaceuticals; medicines; drugs; vaccines; in vivo cell therapies; cells for medical or clinical use; stem cells for medical purposes; cells for medical use; genetically engineered cells; gene therapy products; gene therapy preparations; gene therapy products, namely, genetically engineered cells for transplant purposes; targeted in vivo RNA technologies; targeted lipid nanoparticles for medicinal use; targeted lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for transient cell reprogramming or cell engineering; cell engineering platforms; cell platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gen...
General Information
| Serial Number | 98473700 |
| Word Mark | MULTIPLYING THE POSSIBILITIES |
| Filing Date | Thursday, March 28, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, March 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; systems to express therapeutic proteins in vivo; biopharmaceuticals; medicines; drugs; vaccines; in vivo cell therapies; cells for medical or clinical use; stem cells for medical purposes; cells for medical use; genetically engineered cells; gene therapy products; gene therapy preparations; gene therapy products, namely, genetically engineered cells for transplant purposes; targeted in vivo RNA technologies; targeted lipid nanoparticles for medicinal use; targeted lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for transient cell reprogramming or cell engineering; cell engineering platforms; cell platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gene therapy; |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 28, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CAPSTAN THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 28, 2024 | NEW APPLICATION ENTERED |
| Thursday, March 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
